TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
CRMD

CorMedix Inc

Healthcare · Biotechnology

7.30$ +0.3% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

CorMedix Inc (CRMD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 904 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CRMD
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
91 82 68 58 78 119 150 253 751 826 816 904
89 79 63 53 73 115 145 248 260 367 383 481
53 44 35 29 35 41 66 159 48 146 178 257
87 76 59 46 46 52 78 191 56 150 178 257
– 0.0 0.0 0.2 17 52 55 43 160 171 155 161
– 2.1 2.3 4.0 6.6 7.6 7.5 9.6 29 30 31 39
– – – – – 0.0 – – 18 30 30 30
– – 2.0 1.9 1.9 1.8 1.8 1.7 390 379 369 358
8.2 12 10 12 19 34 35 32 377 421 379 443
7.7 11 9.5 11 18 34 34 32 134 174 129 187
0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.4 1.4 – –
2.4 4.3 2.8 3.3 1.3 1.7 1.9 5.8 20 7.9 13 10
– – – – – – – – 145 145 145 145
83 70 58 46 59 85 115 221 374 405 437 461
-307 -322 -336 -350 -353 -340 -319 -299 -191 -177 -138 -112
57 57 58 58 59 62 69 72 86 94 93 92

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?